A detailed history of Danske Bank A/S transactions in Incyte Corp stock. As of the latest transaction made, Danske Bank A/S holds 6,833 shares of INCY stock, worth $711,656. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,833
Holding current value
$711,656
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025

BUY
$67.27 - $86.96 $5.14 Million - $6.65 Million
76,460 Added 1118.98%
83,293 $7.06 Million
Q3 2025

Nov 13, 2025

BUY
$67.27 - $86.96 $459,655 - $594,197
6,833 New
6,833 $580 Million
Q2 2025

Dec 18, 2025

BUY
$55.17 - $71.22 $2.1 Million - $2.71 Million
38,103 Added 57.33%
104,562 $7.12 Million
Q1 2025

Dec 18, 2025

SELL
$60.0 - $75.26 $1.01 Million - $1.27 Million
-16,834 Reduced 20.21%
66,459 $4.02 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.